Comprehensive approach to the treatment of patients with aesthetic deformity of the anterior abdominal wall with concomitant metabolic disorders

Todurov I.M., Plehutsa O.I., Pylypchuk O.O., Hrynevych A.A.

State Scientific Institution “Center for Innovative Medical Technologies of the National Academy of Sciences of Ukraine”, Kyiv, Ukraine

DOI : https://doi.org/10.57105/2415-7252-2024-2-01

Abstract 

Obesity has become a global healthcare issue of the ХХІ century, being an integral component of the metabolic disturbances that constitute the metabolic syndrome (MS). The vast majority of individuals in this category experience aesthetic deformities of the anterior abdominal wall and are dissatisfied with both their health status and physical appearance. As a result, they primarily seek assistance from plastic surgeons for abdominal wall correction, often overlooking the underlying cause of their condition — excess body weight and metabolic disorders — which may negatively affect treatment outcomes.

Modern conservative approaches to the treatment of obesity and MS, such as diet therapy, lifestyle modification, and pharmacological treatment, demonstrate favorable short-term results. However, in the long-term — particularly among patients with significant excess body weight and severe metabolic disorders — their effectiveness may be insufficient.

Bariatric procedures — currently referred to as metabolic surgeries — such as sleeve gastrectomy and Roux-en-Y gastric bypass, are considered the most effective methods for treating obesity and MS, underscoring their significance in addressing this issue.
Thus, only after implementing conservative or surgical weight-loss interventions and achieving satisfactory results in body weight reduction and improvement or compensation of metabolic syndrome, should patients with aesthetic deformities of the anterior abdominal wall — caused by excess skin and altered abdominal contour — be considered for aesthetic surgical correction, namely abdominoplasty.

Therefore, a comprehensive approach to treating patients with anterior abdominal wall deformities and concurrent MS involves initially pursuing conservative or surgical weight-loss strategies and achieving metabolic control or improvement, followed by plastic and reconstructive surgery. This strategy ensures minimal risk of postoperative complications after abdominoplasty, maximal efficacy and safety, ultimately leading to significant improvements in patients’ quality of life, physical well-being, and psychological state.

Keywords: comprehensive approach, aesthetic deformity, anterior abdominal wall, metabolic syndrome, obesity, bariatric surgery, combined abdominoplasty

References:

  1. World Health Organization. (2019). Global report on obesity. Geneva: WHO.
  2. Purnell, J.Q. Obesity and metabolic syndrome: current state and future challenges. Endocrinology and Metabolism Clinics of North America. 2020.
  3. Ziesmann, M.T., et al. “Complications in abdominal surgery and the metabolic syndrome.” Surgical Clinics of North America. 2017.
  4. Schuster, M. and Smith, P. “Approach to bariatric surgery and plastic reconstructive surgery.” Aesthetic Surgery Journal. 2018.
  5. Schuster, M. and Smith, P. “Approach to bariatric surgery and plastic reconstructive surgery.” Aesthetic Surgery Journal. 2018.
  6. Song, A. Y., Rubin, J. P., Thomas, V., Dudas, J. R., Marra, K. G., & Fernstrom, M. H. (2016). Body image and quality of life in post massive weight loss body contouring patients. Obesity, 14(9), 1626–1636. https://doi.org/10.1038/oby.2006.187
  7. Giordano, S., Victorzon, M., Stormi, T., & Saariniemi, K. M. (2020). Quality of life and satisfaction after body contouring surgery in post-bariatric patients: A cross-sectional study. Journal of Plastic, Reconstructive & Aesthetic Surgery, 73(1), 163–170. https://doi.org/10.1016/j.bjps.2019.09.014
  8. Caballero B. (2019). Humans against Obesity: Who Will Win?. Advances in nutrition(Bethesda, Md.),10(suppl_1),S4–S9. https://doi.org/10.1093/advances/nmy055
  9. Sadeghi, P., Duarte-Bateman, D., Ma, W., Khalaf, R., Fodor, R., Pieretti, G., Ciccarelli, F., Harandi, H., & Cuomo, R. (2022). Post-Bariatric Plastic Surgery: Abdominoplasty, the State of the Art in Body Contouring. Journal of clinical medicine, 11(15),4315. https://doi.org/10.3390/jcm11154315
  10. Scopinaro N. (2014). Bariatric metabolic surgery. Rozhledy v chirurgii :mesicnik Ceskoslovenske chirurgicke spolecnosti, 93(8),404–415.
  11. Carneiro, I. G., de Oliveira, J. L., & Pinheiro, J. A. (2014). Abdominal Skin Changes After Bariatric Surgery: Prevalence and Management.Obesity Surgery, 24(8), 1266-1272.
  12. Горопашна, С. А., & Горошко, В. І. (2023). РЕАБІЛІТАЦІЙНЕ ВІДНОВЛЕННЯ ПІСЛЯ АБДОМІНОПЛАСТИКИ. RehabilitationandRecreation, (14), 12–18. https://doi.org/10.32782/2522-1795.2023.14.1
  13. Shestak K.C. Marriage abdominoplasty expands the miniabdominoplasty concept / K.C. Shestak // Plast. Reconstr. Surg. – 2008. – Vol. 103, N. 5. – P. 10-20.
  14. Голобородько О. П., Лисак В. В., Лисак О. В. та ін. Абдомінопластика: обґрунтування доцільності, ризики та ускладнення: Монографія. – Полтава: Вид-во ПНПУ ім. В. Г. Короленка, 2020. – 124 с. (стор. 11–12).
  15. Бойко В. В., Тарабан І. А., Мишеніна Є. В. (2012). Сучасні аспекти абдомінопластики. ДУ «Інститут загальної та невідкладної хірургії НАМН України», м. Харків. Харківська хірургічна школа, №3 (54), 113–117
  16. Gu Z, Zhu P, Wang Q, He H, Xu J, Zhang L, Li D, Wang J, Hu X, Ji G, Zhang L, Liu B. Obesity and lipid-related parameters for predicting metabolic syndrome in Chinese elderly population. Lipids Health Dis. 2018 Dec 20;17(1):289. doi: 10.1186/s12944-018-0927-x. PMID: 30572889; PMCID: PMC6302378
  17. Saklayen M. G. (2018). The Global Epidemic of the Metabolic Syndrome. Current hypertension reports, 20(2), 12. https://doi.org/10.1007/s11906-018-0812-z
  18. Gu Z, Zhu P, Wang Q, He H, Xu J, Zhang L, Li D, Wang J, Hu X, Ji G, Zhang L, Liu B. Obesity and lipid-related parameters for predicting metabolic syndrome in Chinese elderly population. Lipids Health Dis. 2018 Dec 20;17(1):289. doi: 10.1186/s12944-018-0927-x. PMID: 30572889; PMCID: PMC6302378
  19. Frayling, T. M., Timpson, N. J., & Wills, A. C. (2007). A Common Variant in the FTO Gene Is Associated with Body Fat and Predisposes to Childhood and Adult Obesity. Science, 316(5826), 889-894.
  20. American Diabetes Association. (2003). Standards of Medical Care for Patients with Diabetes Mellitus. Diabetes Care, 26(Suppl 1), S33-S50
  21. Kershaw, E. E., & Flier, J. S. (2004). Adipose Tissue as an Endocrine Organ. Journal of Clinical Endocrinology & Metabolism, 89(6), 2548-2558.
  22. Swinburn, B. A., Sacks, G., & Hall, K. D. (2011). The Global Obesity Pandemic: Shaped by Global Drivers and Local Environments. The Lancet, 378(9793), 804-814.
  23. Popkin, B. M. (2006). Global Nutrition Dynamics: The World Is Shifting Rapidly Toward a Diet Linked with Noncommunicable Diseases. The American Journal of Clinical Nutrition, 84(2), 289-298
  24. Eckel, R. H., Kahn, R., Ferrannini, E., & Scherer, P. E. (2005). Obesity and Type 2 Diabetes: What Can We Learn from Genetics? The Journal of Clinical Endocrinology & Metabolism, 90(2), 787-794.
  25. Rosen, E. D., & Spiegelman, B. M. (2014). Molecular Regulation of Adipogenesis. Annual Review of Cell and Developmental Biology, 16, 145-171.
  26. Hotamisligil, G. S. (2006). Inflammation and Metabolic Disorders. Nature, 444(7121), 860-867.
  27. Wilson, P. W. F., D’Agostino, R. B., Parise, H., Sullivan, L., & Meigs, J. B. (1998). Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus. Circulation, 118(7), 761-768.
  28. Zhao, X., Wang, C., & Wang, D. (2015). Waist Circumference and Waist-to-Hip Ratio as Indicators of Abdominal Fat Distribution in the Metabolic Syndrome. Obesity Research & Clinical Practice, 9(2), 123-131.
  29. Jensen, M. D., Ryan, D. H., & Apovian, C. M. (2014). Treatment of Overweight and Obesity in Adults: 2013 AHA/ACC/TOS Guideline. Circulation, 129(25_suppl_2), S102-S138.
  30. American Diabetes Association. (2020). Standards of Medical Care in Diabetes—2020. Diabetes Care, 43(Supplement 1), S1-S212.
  31. WHO, 2019.
  32. Matthews, D. R., Hosker, J. P., & Rudenski, A. S. (1985). Homeostasis Model Assessment: Insulin Resistance and Beta-cell Function from Fasting Plasma Glucose and Insulin Concentrations in Man. Diabetologia, 28(7), 412-419.
  33. Whelton, P. K., Carey, R. M., & Aronow, W. S. (2018). 2017 Guideline for High Blood Pressure in Adults. Journal of the American College of Cardiology, 71(19), 2199-2260.
  34. Grundy, S. M., Cleeman, J. I., & Daniels, S. R. (2005). Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112(17), 2735-2752.
  35. Browning, J. D., Szczepaniak, L. S., & Dobbins, R. (2004). Prevalence of Hepatic Steatosis in an Adult Population. Gastroenterology, 126(2), 453-460.
  36. Zieve F. J. (2004). The metabolic syndrome: diagnosis and treatment. Clinical cornerstone, 6 Suppl 3, S5–S13. https://doi.org/10.1016/s1098-3597(04)80093-0
  37. Nauck, M. A., & Meier, J. J. (2019). Management of endocrine disease: Are all GLP-1 agonists equal in the treatment of type 2 diabetes and beyond? European Journal of Endocrinology, 181(6), R211–R234. https://doi.org/10.1530/EJE-19-0563
  38. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., … & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
  39. Rubino, D. M., Greenway, F. L., Khalid, U., O’Neil, P. M., Rosenstock, J., Sørrig, R., … & Davies, M. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224
  40. Тодуров І. М., Білянський Л. С., Перехрестенко О. В., Роздобудько Ю. М., Кучерюк В. В., Калашніков О. О., Плегуца О. І. (2015). Ефективність “рукавної” резекції шлунка в лікуванні хворих з ожирінням. Клінічна хірургія, 6, 5–8.
  41. Wolfe, B. M., Kvach, E., & Eckel, R. H. (2016). Treatment of Obesity: Weight Loss and Bariatric Surgery. Circulation research, 118(11), 1844–1855. https://doi.org/10.1161/CIRCRESAHA.116.307591
  42. Surg Obes Relat Dis 2022; https://doi.org/10.1016/j.soard. 2022.08.01
  43. Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., … & Nissen, S. E. (2017). Bariatric surgery versus intensive medical therapy for diabetes — 5-year outcomes. New England Journal of Medicine, 376(7), 641–651. https://doi.org/10.1056/NEJMoa1600869
  44. Arterburn, D. E., Telem, D. A., Kushner, R. F., & Courcoulas, A. P. (2020). Benefits and risks of bariatric surgery in adults: A review. JAMA,324(9), 879–887. https://doi.org/10.1001/jama.2020.12567
  45. Panunzi, S., Carlsson, L., De Gaetano, A., Spagnuolo, L., Jacobson, B., Sjöström, L., … & Mingrone, G. (2013). Determinants of diabetes remission and glycemic control after bariatric surgery. The Lancet Diabetes & Endocrinology, 1(1), 37–44. https://doi.org/10.1016/S2213-8587(13)70003-6
  46. Cummings, D. E., Cohen, R. V., & Glazer, B. (2016). Metabolic surgery for treatment of type 2 diabetes. Nature Reviews Endocrinology, 12(2), 91–100. https://doi.org/10.1038/nrendo.2015.205
  47. Vishvanath L, Gupta RK. Contribution of adipogenesis to healthy adipose tissue expansion in obesity. J Clin Invest. 2019 Oct 1;129(10):4022-4031. doi: 10.1172/JCI129191. PMID: 31573549; PMCID: PMC6763245.
  48. Blaszczak AM, Jalilvand A, Hsueh WA. Adipocytes, Innate Immunity and Obesity: A Mini-Review. Front Immunol. 2021 Jun 24;12:650768. doi: 10.3389/fimmu.2021.650768. PMID: 34248937; PMCID: PMC8264354.
  49. Jialal I, Devaraj S. Subcutaneous adipose tissue biology in metabolic syndrome. Horm Mol Biol Clin Investig. 2018 Jan 20;33(1). doi: 10.1515/hmbci-2017-0074. PMID: 29353263.
  50. Ma D, Wang Y, Zhou G, Wang Y, Li X. Review: the Roles and Mechanisms of Glycoprotein 130  in the Regulation of Adipocyte Biological Function. Inflammation. 2019 Jun;42(3):790-798. doi: 10.1007/s10753-019-00959-6. PMID: 30661143.
  51. Müller, M., et al. (2017). Timing of body contouring surgery after massive weight loss. Aesthetic Surgery Journal, 37(7), 745-752.
  52. Bianchi, L., et al. (2015). Timing of abdominoplasty in post-weight loss patients. Obesity Surgery, 25(9), 1663-1670.
  53. Jasso, G., et al. (2019). Outcomes of abdominoplasty after bariatric surgery. Plastic and Reconstructive Surgery, 143(3), 633-641.
  54. Van der Heijden, S. J., et al. (2019). Metabolic syndrome and complications after weight loss surgery. Obesity Surgery, 29(6), 1865-1872.
  55. Hernandez, S. R., et al. (2020). Impact of bariatric surgery on quality of life and post-abdominoplasty outcomes. Journal of Obesity & Metabolic Research, 12(4), 162-169.
  56. Akin, I., et al. (2019). Recurrence of obesity after abdominoplasty: Long-term follow-up results. Journal of Plastic, Reconstructive & Aesthetic Surgery, 72(10), 1622-1629.
  57. Sjöström, L., Peltonen, M., Jacobson, P., Ahlin, S., Andersson-Assarsson, J. C., Anveden, Å., … & Carlsson, L. M. S. (2017). Association of bariatric surgery with changes in quality of life and body image. JAMA Surgery, 152(9), 819–827. https://doi.org/10.1001/jamasurg.2017.1237
  58. Carlsson, L. M. S., Sjöholm, K., Jacobson, P., Andersson-Assarsson, J. C., Svensson, P. A., Taube, M., … & Sjöström, L. (2020). Life expectancy after bariatric surgery in the Swedish Obese Subjects study. New England Journal of Medicine, 383(16), 1535–1543. https://doi.org/10.1056/NEJMoa2002449
  59. Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., … & Rubino, F. (2021). Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. The Lancet, 397(10271), 293–304. https://doi.org/10.1016/S0140-6736(20)32649-0
  60. Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., … & Rubino, F. (2021). Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. The Lancet, 397(10271), 293–304. https://doi.org/10.1016/S0140-6736(20)32649-0
  61. Ahmed, H. O., Arif, S. H., Abdulhakim, S. A., Kakarash, A., Ali Omer, M. A., Nuri, A. M., Omer, H. H., Jalal, H. K., Omer, S. H., & Muhammad, N. A. (2018). Gender difference in requesting abdominoplasty, after bariatric surgery: Based on five years of experience in two centers in Sulaimani Governorate, Kurdistan Region/Iraq. International journal of surgery (London, England), 56, 155–160. https://doi.org/10.1016/j.ijsu.2018.06.017
  62. Hultman, C. S., Lundgren, L. O., & Owe, M. (2017). The Effectiveness of Abdominoplasty for Improving Body Image and Quality of Life in Post-bariatric Surgery Patients. Aesthetic Surgery Journal, 37(4), 438-446.
  63. Carneiro, I. G., de Oliveira, J. L., & Pinheiro, J. A. (2014). Abdominal Skin Changes After Bariatric Surgery: Prevalence and Management.Obesity Surgery, 24(8), 1266-1272.
  64. Gauglitz, G. G., Korting, H. C., & Olsson, M. J. (2011). Laser and Light Therapy for the Management of Stretch Marks. Journal of Cosmetic Dermatology, 10(1), 52-61.
  65. Maghsoudi, H., Jones, A., & Ginsberg, J. (2018). Post-bariatric Body Contouring: Clinical Outcomes and Patient Satisfaction. Plastic and Reconstructive Surgery, 141(3), 533-541.
  66. Mochizuki, Y., Kasai, M., & Maeda, M. (2015). Muscle Tone and Skin Elasticity After Massive Weight Loss. Journal of Clinical Biochemistry and Nutrition, 57(2), 149-156.
  67. Aparicio, C., Asín, M. A., & Benito, M. (2012). Changes in Skin Elasticity and Collagen After Massive Weight Loss. Journal of Plastic, Reconstructive & Aesthetic Surgery, 65(11), 1558-1565.
  68. Dixon, J. B., O’Brien, P. E., & Playfair, J. (2014). Long-term Outcomes of Bariatric Surgery. Obesity Reviews, 15(3), 183-192.
  69. Nourbakhsh, M., Besharat, S., & Asgarian-Omran, H. (2017). Postoperative Care and Management Following Bariatric Surgery. Obesity Surgery, 27(7), 1842-1851.

 

PDF (українська)

Published
2025

How to Cite

Todurov I.M., Plehutsa O.I., Pylypchuk O.O., Hrynevych A.A. (2025). Comprehensive approach to the treatment of patients with aesthetic deformity of the anterior abdominal wall with concomitant metabolic disorders. Diabetes Obesity Metabolic Syndrome. 4(14), 53-64.